🇺🇸 FDA
Patent

US 9206411

Staphylococcal Phage2638A endolysin amidase domain is lytic for Staphylococcus aureus

granted A61KA61K38/00A61P

Quick answer

US patent 9206411 (Staphylococcal Phage2638A endolysin amidase domain is lytic for Staphylococcus aureus) held by The United States of America, as represented by the Secretary of Agriculture expires Mon Dec 03 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary of Agriculture
Grant date
Tue Dec 08 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 03 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K38/00, A61P, A61P31/04